Latest News and Press Releases

Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trialActively dosing patients in OCU400 Phase 3 liMeliGhT clinical...

Aemetis to Review Second Quarter 2025 Financial Results on August 7, 2025

RICHMOND, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company today announced that the company has scheduled the release of its second...

Nephros Schedules Second Quarter 2025 Financial Results Conference Call

VedTechBio enhances RxAgentAI platform; teams with US-based AlphaMeld to cut drug discovery time and co-develop therapies for rare and metabolic diseases.

VedTechBio enhances RxAgentAI platform; teams with US-based AlphaMeld to cut drug discovery time and co-develop therapies for rare and metabolic diseases.

KIGALI, Rwanda and SAN FRANCISCO and AUBAGNE, France, July 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology, Ltd. (Bio Usawa), a leading African biotechnology firm, and Sartorius Stedim Biotech,...

Madison, Wisconsin, July 29, 2025 (GLOBE NEWSWIRE) -- The Wisconsin Economic Development Corporation (WEDC) has approved a 25% tax credit for investors in a groundbreaking diabetes cure being...

Conference Call and Webcast Scheduled for Thursday, August 7th, 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company...

KIGALI, Rwanda and SAN FRANCISCO and ACCRA, Ghana , July 28, 2025 (GLOBE NEWSWIRE) -- Bio Usawa, a pioneering private biotechnology company committed to developing and manufacturing affordable,...